AU2001290629A1 - Heat shock response and virus replication - Google Patents

Heat shock response and virus replication

Info

Publication number
AU2001290629A1
AU2001290629A1 AU2001290629A AU9062901A AU2001290629A1 AU 2001290629 A1 AU2001290629 A1 AU 2001290629A1 AU 2001290629 A AU2001290629 A AU 2001290629A AU 9062901 A AU9062901 A AU 9062901A AU 2001290629 A1 AU2001290629 A1 AU 2001290629A1
Authority
AU
Australia
Prior art keywords
heat shock
virus replication
shock response
response
replication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001290629A
Inventor
Matthew Cotten
Brian Hjelle
Pope L. Moseley
Antonito Panganiban
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
UNM Rainforest Innovations
Original Assignee
SCIENCE AND TECHNOLOGY CORP UN
Boehringer Ingelheim International GmbH
STC UNM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SCIENCE AND TECHNOLOGY CORP UN, Boehringer Ingelheim International GmbH, STC UNM filed Critical SCIENCE AND TECHNOLOGY CORP UN
Publication of AU2001290629A1 publication Critical patent/AU2001290629A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001290629A 2000-09-07 2001-09-06 Heat shock response and virus replication Abandoned AU2001290629A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23064900P 2000-09-07 2000-09-07
US60230649 2000-09-07
US60/230,649 2000-09-07
PCT/US2001/027554 WO2002019965A2 (en) 2000-09-07 2001-09-06 Heat shock response and virus replication

Publications (1)

Publication Number Publication Date
AU2001290629A1 true AU2001290629A1 (en) 2002-03-22

Family

ID=22866043

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001290629A Abandoned AU2001290629A1 (en) 2000-09-07 2001-09-06 Heat shock response and virus replication

Country Status (3)

Country Link
US (1) US20050233963A1 (en)
AU (1) AU2001290629A1 (en)
WO (1) WO2002019965A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010600A1 (en) * 2001-10-04 2003-04-04 Brane Tech S R L FLAVONOID COMPOUNDS CAPABLE OF MODIFYING THE PHYSICAL AND / OR DYNAMIC STATE OF BIOLOGICAL MEMBRANES AND OF STIMULATING THE ENDOGENIC SYNTHESIS OF PROTEIN
WO2004081199A2 (en) * 2003-03-11 2004-09-23 Genentech, Inc. Novel compositions and methods for the treatment of immune related disease
WO2008091241A1 (en) * 2005-12-02 2008-07-31 Board Of Regents, The University Of Texas System Development of influenza a antivirals
US7709190B2 (en) 2005-12-02 2010-05-04 Board Of Regents, The University Of Texas System Influenza A virus vaccines and inhibitors
US7601490B2 (en) * 2005-12-02 2009-10-13 Board Of Regents, The University Of Texas System Development of influenza A antivirals
CN102579659A (en) * 2012-03-16 2012-07-18 武汉大学 Application of flavonoids of litchi seeds in preparation of anti-adenovirus medicament
EP2929045B1 (en) 2012-12-05 2020-12-02 SOLA Biosciences LLC Protein expression enhancing polypeptides
WO2016088028A1 (en) 2014-12-01 2016-06-09 Cape Kingdom Nutraceuticals (Pty) Ltd Anti-viral therapeutic compositions
EP3277271B1 (en) * 2015-03-31 2021-07-21 Turtle Bear Holdings, LLC Antiviral activity from medicinal mushrooms and their active constituents
US20190330635A1 (en) * 2017-01-24 2019-10-31 Li-Min Huang Antiviral agent and method for treating viral infection
CN109939099A (en) * 2019-03-26 2019-06-28 青岛大学附属医院 Myricetin is preparing the application in drug and health care product for preventing and treating illness caused by herpes simplex virus
CN114364804A (en) * 2019-04-12 2022-04-15 马萨诸塞眼科耳科诊所 Methods and compositions for improving adeno-associated virus (AAV) assembly
CN111803485B (en) * 2020-06-17 2022-12-20 中国人民解放军第四军医大学 Application of compound AN-329 in inhibiting hantavirus release diffusion
CN115400121B (en) * 2022-04-29 2023-05-23 佛山病原微生物研究院 Application of SNX-2112 in preparation of medicines for resisting adenovirus infection
CN114917222B (en) * 2022-04-29 2023-02-28 佛山病原微生物研究院 Application of Ganetespib in preparation of medicine for resisting adenovirus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US5034506A (en) * 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages

Also Published As

Publication number Publication date
US20050233963A1 (en) 2005-10-20
WO2002019965A2 (en) 2002-03-14
WO2002019965A3 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
AU2002246534A1 (en) Resistive heaters and uses thereof
AU2002221036A1 (en) Heat exchanger tube and heat exchanger
AU4443901A (en) Heat and moisture exchanger
AUPQ801700A0 (en) Enzyme and viral activation
AU2002225681A1 (en) Yeast-dentritic cell vaccines and uses thereof
AU2001282398A1 (en) Vibration and shock resistant heat sink assembly
AU2001290629A1 (en) Heat shock response and virus replication
AU2002221749A1 (en) Synthetic viruses and uses thereof
AU2001277526A1 (en) Substituted benzo-nitro-heterocycles and use thereof as herbicides
AUPQ912000A0 (en) Improved virus like particles
GB0017720D0 (en) Modified virus
AU8254301A (en) Optical disc and physical address format
AU2002211717A1 (en) Stresscopins and their uses
AU2001272011A1 (en) Siderophores-producing bifidobacteria thereby and uses thereof
AU2002307971A1 (en) Vaccine against the nile fever virus
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2001262149A1 (en) 2-(indanylamino)pyrimidone and 2-(tetrahydronaphthalenylamino)pyrimidone derivatives
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU4529401A (en) Aids ancestral viruses and vaccines
AU6962698A (en) Transgenomic viruses and the use thereof
AU2002243257A1 (en) Oncolytic virus
AU2001276258A1 (en) Ceramic component and the use thereof
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2001234180A1 (en) Benzamide derivative and use thereof